Literature DB >> 8967794

Differential uptake of chloroquine by human keratinocytes and melanocytes in culture.

G Sjölin-Forsberg1, B Berne, M Johansson, M J Olsson, O Rollman.   

Abstract

The antimalarial drug chloroquine has a high affinity for melanin and accumulates in melanin-rich compartments such as those of the eye. Chloroquine is also deposited in cutaneous tissue, but whether the drug distribution is restricted to melanin-producing cells of the skin is not known. In the present study, the uptake of chloroquine by normal human epidermal keratinocytes was compared with that by melanocytes. Selectively cultivated cells were incubated at drug concentrations ranging between 0 and 10000 ng/ml for periods of up to 48 h. Chloroquine was quantified in cells and medium using high performance liquid chromatography and fluorometric detection. In both types of cells there was a rapid uptake of chloroquine within the first 2 h, followed by a slower uptake for 2-6 h until a steady-state condition was reached. Dose dependency was linear, with no sign of saturation, and approximately ten times higher drug concentrations were attained in melanocytes as compared with keratinocytes. No formation of desethylchloroquine, the major systemic metabolite, was detected in either cell type. The observed affinity of chloroquine for normal epidermal melanocytes in vitro suggests that the density and melanogenic activity of skin pigment cells may influence the cutaneous drug disposition of chloroquine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967794     DOI: 10.1007/BF02505226

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  23 in total

1.  Studies on the mechanism of drug-binding to melanin.

Authors:  B Larsson; H Tjälve
Journal:  Biochem Pharmacol       Date:  1979-04-01       Impact factor: 5.858

Review 2.  Antimalarials in the management of discoid and systemic lupus erythematosus.

Authors:  E L Dubois
Journal:  Semin Arthritis Rheum       Date:  1978-08       Impact factor: 5.532

3.  The molecular basis of the action of chloroquine in porphyria cutanea tarda.

Authors:  P L Scholnick; J Epstein; H S Marver
Journal:  J Invest Dermatol       Date:  1973-10       Impact factor: 8.551

4.  Chloroquine accumulation n human eyes.

Authors:  T Lawwill; B Appleton; L Altstatt
Journal:  Am J Ophthalmol       Date:  1968-04       Impact factor: 5.258

5.  Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography.

Authors:  G Alván; L Ekman; B Lindström
Journal:  J Chromatogr       Date:  1982-04-16

6.  The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography.

Authors:  N G Lindquist; S Ullberg
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1972

7.  Evidence for intercalation of chloroquine into DNA.

Authors:  R L O'Brien; J L Allison; F E Hahn
Journal:  Biochim Biophys Acta       Date:  1966-12-21

8.  Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring.

Authors:  G M Murphy; J L Hawk; I A Magnus
Journal:  Br J Dermatol       Date:  1987-03       Impact factor: 9.302

9.  Repigmentation of vitiligo by transplantation of cultured autologous melanocytes.

Authors:  M J Olsson; L Juhlin
Journal:  Acta Derm Venereol       Date:  1993-02       Impact factor: 4.437

10.  Chloroquine phosphate: a long-term follow-up of drug concentrations in skin suction blister fluid and plasma.

Authors:  G Sjölin-Forsberg; B Berne; C Blixt; M Johansson; B Lindström
Journal:  Acta Derm Venereol       Date:  1993-12       Impact factor: 4.437

View more
  1 in total

1.  Chloroquine-induced Pruritus.

Authors:  S E Aghahowa; H O Obianwu; A O Isah; I M Arhewoh
Journal:  Indian J Pharm Sci       Date:  2010-05       Impact factor: 0.975

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.